Archana Shanker and Drishi Kaur of Anand and Anand discuss the often ambiguous requirements of section 8 of the Indian Patents Act The disclosure of foreign filing to the Indian Patent Office is a ...

“The lack of understanding around the scope and intent of Directive 2001/83/EC of the European Parliament is responsible for the existing debate and controversy concerning section 3(d) of the Indian ...

India's Section 107A (Bolar exemption) allows generics to conduct R&D on patented drugs for regulatory approval, accelerating market entry after patent expiry. “The principle behind the Bolar ...

Bringing a new life into the world through a C-section is a profound journey, but the postpartum recovery after C section can feel equally overwhelming. For many Indian mums, the mix of physical pain, ...